Fast Market Research

Global Retinal Vein Occlusion Market 2014-2018 - New Market Report

New Healthcare research report from TechNavio is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 07/31/2014 -- Retinal vein occlusion is a medical condition where there is a blockage in the retinal veins. This blocks the flow of blood in the retina, which can damage the nerve cells of the eye and result in loss of vision. Retinal vein occlusion can occur as a result of a clot in a vein, especially if the veins of the eye are very narrow. The disease is likely to affect people who are already suffering from hypertension, diabetes mellitus, or hyperlipidaemia. Retinal vein occlusion is one of the most common causes of blindness after diabetic retinopathy. It is also one of the most common vascular disorders of the eye. Retinal vein occlusion can be broadly classified into two types, central retinal vein occlusion and branch retinal vein occlusion, with the latter being more frequent. Central retinal vein occlusion can be divided into two further subtypes, ischemic central retinal vein occlusion and non-ischemic central retinal vein occlusion.

View Full Report Details and Table of Contents

TechNavio's analysts forecast the Global Retinal Vein Occlusion market will grow at a CAGR of 16.04 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Retinal Vein Occlusion market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of retinal vein occlusion.

TechNavio's report, the Global Retinal Vein Occlusion Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Retinal Vein Occlusion market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas

Key Vendors

- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

- Alimera Sciences
- Bristol-Myers Squibb
- NicOx
- Santen Pharmaceutical Co.
- Valeant Pharmaceuticals International

Key Market Driver

- High Unmet Need
- For a full, detailed list, view our report.

Key Market Challenge

- Serious Adverse Side Effects
- For a full, detailed list, view our report.

Key Market Trend

- Introduction of Biologics
- For a full, detailed list, view our report.

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Alimera Sciences, Bristol-Myers Squibb, NicOx, Santen Pharmaceutical Co., Valeant Pharmaceuticals International

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Retinal Vein Occlusion - Pipeline Review, H1 2014
- Retinal Vein Occlusion - Pipeline Review, H2 2013
- Global Ophthalmic Diagnostic Devices Market 2014-2018
- Medical Equipment Quarterly Deals Analysis: M&A and Investment Trends - Q2 2013
- GlobalIVDProductsandTestMarket- StrategicVolumeandPricingAnalysis2012-2016
- Global Palm Vein Biometrics Market 2012-2016
- Macular Edema - Pipeline Review, H2 2013
- The Global Government Biometric Systems Market 2014-2024
- Retinal Degeneration - Pipeline Review, H1 2014
- Retinal Degeneration - Pipeline Review, H2 2013